Food Safety News |
Supplement linked to liver failure, hepatitis recalled
UPI.com “As soon as we suspected a possible link between OxyElite Pro products and cases of liver failure and non-viral hepatitis in Hawaii, we warned the public and immediately began an investigation with state officials and the Centers for Disease Control … Woman files suit in dietary supplement case tied to liver failureHonolulu Star-Advertiser Diet Supplement Recalled After Being Linked to Liver Failure and DeathFood Consumer OxyElite Pro Supplements RecalledFDA.gov Food Safety News –Courthouse News Service all 80 news articles » |
Girl, seven, died of liver and heart failure three days after medics … – Daily Mail
Daily Mail |
Girl, seven, died of liver and heart failure three days after medics …
Daily Mail But despite having blue lips – a sign of organ failure – Dr Raka Banerjee said the schoolgirl was ‘fine’ and sent her home. Discharged: Simran Dhesi, seven, was released from the Accident and Emergency department at Sandwell … But the following day … Parents of tragic Simran say lessons must be learnedexpressandstar.com |
Girl, seven, died of liver and heart failure three days after bungling medics … – Daily Mail
|
Girl, seven, died of liver and heart failure three days after bungling medics …
Daily Mail But despite having blue lips – a sign of organ failure – Dr Raka Banerjee said the schoolgirl was ‘fine’ and sent her home. Discharged: Simran Dhesi, seven, was released from the Accident and Emergency department at Sandwell … But the following day … |
Cadila launches Mycidac-C for treatment of lung cancer – NetIndian
|
Cadila launches Mycidac-C for treatment of lung cancer
NetIndian “Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets Desmocolin-3, a novel target … |
Cadila Pharmaceuticals launches lung cancer drug – Economic Times
|
Cadila Pharmaceuticals launches lung cancer drug
Economic Times As per the company’s statement, Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets … |
Cadila unveils lung cancer drug priced at Rs 40000 for 10 shots – Hindu Business Line
|
Cadila unveils lung cancer drug priced at Rs 40000 for 10 shots
Hindu Business Line According to the World Health Organization (WHO), 1.25 million people are diagnosed with lung cancer annually. “This is the first novel product for cancer management from India,” Modi said, adding that “hundreds of crores” have been spent in developing … |
Cadila Pharma launches affordable lung cancer drug – Business Standard (blog)
Business Standard (blog)Cadila Pharma launches affordable lung cancer drugBusiness Standard (blog)Ahmedabad-based Cadila Pharmaceuticals Limited, a privately held pharma company, has launched the Mycidac-C, an affordable, unique and innovative drug for…
Research and Markets: Global Cancer Monoclonal Antibodies Pipeline Analysis – Business Wire (press release)
Research and Markets: Global Cancer Monoclonal Antibodies Pipeline AnalysisBusiness Wire (press release)In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selective…
Making life better for heart failure patients – Blackpool Gazette
Making life better for heart failure patientsBlackpool GazetteThe 12-month project will offer patients treated for heart failure a 10-week programme of activities aimed at giving them the tools and information they need to self-manage their condition. …
Posthumous award for bike crash victim organ donor – Get Surrey
|
Posthumous award for bike crash victim organ donor
Get Surrey … their organs. “These families are an inspiration to all. With around three people dying every day due to the shortage of organs, we hope these families’ pride will encourage many more to follow in their footsteps and agree to become an organ donor … |